The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. FDA has approved TREMFYA for adult patients with...
Read moreCatalent and Humanigen, Inc. announced the expansion of their relationship, under which Catalent will provide development, manufacturing and commercialization services...
Read moreThermo Fisher Scientific and First Genetics JCS, a manufacturer of diagnostic equipment and IVD kits intended to advance molecular genetic...
Read moreIn a landmark development for COVID-19 patients in India, Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, announced the launch...
Read moreGilead Sciences, Inc. announced topline results from the Phase 3 SIMPLE trial in hospitalized patients with moderate COVID-19 pneumonia. This...
Read moreOxford Biomedica plc, a leading gene and cell therapy group, announced that it has signed a Collaboration Agreement with the...
Read moreTakeda Pharmaceutical Company Limited announced it will orally present the results of two studies at the 25th Congress of the...
Read moreThe drug development firm has introduced COVID-19 Clinical Trial Connect, a site designed to help potential patients match with research...
Read moreJohnson & Johnson announced that through its Janssen Pharmaceutical Companies (Janssen) it has accelerated the initiation of the Phase 1/2a...
Read moreKite, a Gilead Company announced it has received approval to implement a variation to the Yescarta® (axicabtagene ciloleucel) Marketing Authorization...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.